Manami Inoue1, Shoichiro Tsugane2. 1. Division of Prevention, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. mnminoue@ncc.go.jp. 2. Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Abstract
PURPOSE OF REVIEW: We reviewed the available literature on observational studies, meta-analyses, expert reports, and umbrella reviews. Here, we summarize the latest findings on the association between coffee intake and liver cancer risk. RECENT FINDINGS: Most observational studies and meta-analyses show a protective effect of coffee intake on liver cancer risk, with dose-responsiveness and across different populations, and regardless of hepatitis virus infection status. Risk reduction by coffee consumption has also been observed for chronic liver diseases. Potential mechanisms include the effect of a number of bioactive compounds such as caffeine, chlorogenic acids, phenolic compounds and diterpenes; antioxidant properties; induction of defense mechanisms; and anti-inflammatory properties. Other potential mechanisms include improvement in insulin sensitivity and prevention of metabolic syndrome and diabetes. Accumulated evidence, with consistency across study designs and populations, suggests that coffee intake probably reduces the risk of liver cancer. Future research should aim to elucidate the mechanism of this preventive effect with establishing the causality of an association.
PURPOSE OF REVIEW: We reviewed the available literature on observational studies, meta-analyses, expert reports, and umbrella reviews. Here, we summarize the latest findings on the association between coffee intake and liver cancer risk. RECENT FINDINGS: Most observational studies and meta-analyses show a protective effect of coffee intake on liver cancer risk, with dose-responsiveness and across different populations, and regardless of hepatitis virus infection status. Risk reduction by coffee consumption has also been observed for chronic liver diseases. Potential mechanisms include the effect of a number of bioactive compounds such as caffeine, chlorogenic acids, phenolic compounds and diterpenes; antioxidant properties; induction of defense mechanisms; and anti-inflammatory properties. Other potential mechanisms include improvement in insulin sensitivity and prevention of metabolic syndrome and diabetes. Accumulated evidence, with consistency across study designs and populations, suggests that coffee intake probably reduces the risk of liver cancer. Future research should aim to elucidate the mechanism of this preventive effect with establishing the causality of an association.
Authors: Eun Sun Jang; Sook-Hyang Jeong; Sang Hyub Lee; Sung Ho Hwang; So Yeon Ahn; Jaebong Lee; Young Soo Park; Jin Hyoek Hwang; Jin-Wook Kim; Nayoung Kim; Dong Ho Lee; Hyun Young Kim Journal: Liver Int Date: 2013-05-08 Impact factor: 5.828
Authors: Gang Hu; Jaakko Tuomilehto; Eero Pukkala; Timo Hakulinen; Riitta Antikainen; Erkki Vartiainen; Pekka Jousilahti Journal: Hepatology Date: 2008-07 Impact factor: 17.425
Authors: Veronica Wendy Setiawan; Lynne R Wilkens; Shelly C Lu; Brenda Y Hernandez; Loïc Le Marchand; Brian E Henderson Journal: Gastroenterology Date: 2014-10-08 Impact factor: 22.682
Authors: G Y Lai; S J Weinstein; D Albanes; P R Taylor; K A McGlynn; J Virtamo; R Sinha; N D Freedman Journal: Br J Cancer Date: 2013-07-23 Impact factor: 7.640
Authors: K Wakai; Y Kurozawa; A Shibata; Y Fujita; K Kotani; I Ogimoto; M Naito; K Nishio; H Suzuki; T Yoshimura; A Tamakoshi Journal: Br J Cancer Date: 2007-07-17 Impact factor: 7.640